Does APIXABAN Cause Product dose omission in error? 150 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 150 reports of Product dose omission in error have been filed in association with APIXABAN (ELIQUIS). This represents 0.1% of all adverse event reports for APIXABAN.
150
Reports of Product dose omission in error with APIXABAN
0.1%
of all APIXABAN reports
1
Deaths
17
Hospitalizations
How Dangerous Is Product dose omission in error From APIXABAN?
Of the 150 reports, 1 (0.7%) resulted in death, 17 (11.3%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Product dose omission in error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 150 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Product dose omission in error?
DUPILUMAB (7,586)
TOFACITINIB (2,461)
LENALIDOMIDE (618)
PALBOCICLIB (592)
DIROXIMEL (481)
ABALOPARATIDE (457)
NIRAPARIB (428)
RUXOLITINIB (425)
TERIFLUNOMIDE (371)
DIMETHYL (308)
Which APIXABAN Alternatives Have Lower Product dose omission in error Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ